You are here

Beckwith-Wiedemann Sendromu ve Uzamış Hipoglisemi

Beckwith-Wiedemann Syndrome and Prolonged Hypoglycemia

Journal Name:

Publication Year:

Abstract (2. Language): 
Macroglossia, prenatal or postnatal overgrowth, macrosomia, macroglossia, and abdominal wall defects (omphalocele, umbilical hernia, or diastasis recti) permit early recognition of BeckwithWiedemann syndrome. Complications include neonatal hypoglycemia and an increased risk for Wilms tumor, adrenal cortical carcinoma, hepatoblastoma, rhabdomyosarcoma, and neuroblastoma, among others. The frequency of hypoglycemia in this population is between 30% and 50%. The cause of hypoglycemia is unclear but supports a hyperinsulinemia as the major factor. The majority of infants with hypoglycemia will be asymptomatic and have resolution of the hypoglycemia within the first 3 days of life. Less than 5% will have hypoglycemia beyond the neonatal period. As conclusion, in patients with BWS levels of insulin and blood glucose must be monitorized beginning from first hours of life. Hypoglycemia may be prolonged in presence of hyperinsulinemia as like this present case.
Abstract (Original Language): 
Beckwith-Wiedemann sendromu (BWS), makrosomi, makroglossi, karın duvar defektleri, hemihipertrofi ile karakterize prenatal veya postnatal bir aşırı büyüme sendromudur. Hastalığın komplikasyonları arasında wilms tümörü, rabdomyosarkom, nöroblastom gibi embriyonal kanserlerle ve hipoglisemi sayılmaktadır. BWS’lu bebeklerin yaklaşık %30’unda hipoglisemi rastlanmaktadır. Hipoglisemi nedeni tam olarak bilinmemekte ve hiperinsülinemi suçlanmaktadır. BWS’da hipoglisemi genellikle yaşamın ilk üç gününden sonra iyileşmesine rağmen vakaların %5’inde dirençli hipoglisemi devam etmektedir. Sonuç olarak BWS’lu bebeklerde kan şekeri düzeyleri ilk saatlerden itibaren düzenli izlenmeli ve insülin düzeyleri de kontrol edilmelidir. Hiperinsülinemi varlığında hipoglisemi problemi burada sunulan vakada olduğu gibi uzayabilir
26-28

REFERENCES

References: 

1. Cohen MM Jr. Beckwith-Wiedemann syndrome: historical,
clinicopathological, and etiopathogenetic perspectives. Pediatr
Dev Pathol 2005;8:287-304.
2. De León DD, Stanley CA. Mechanisms of disease: advances
in diagnosis and treatment of hyperinsulinism in neonates. Nat
Clin Pract Endocrinol Metab 2007;3:57-68.
3. Hussain K, Cosgrove KE, Shepherd RM, et al. Hyperinsulinemic
hypoglycemia in Beckwith-Wiedemann Syndrome due to
defects in the function of pancreatic beta-cell adenosine
triphosphate-sensitive potassium channels. J Clin Endocrinol
Metab 2005;90:4376–82.
4. Fukuzawa R, Umezawa A, Morikawa Y, et al. Nesidioblastosis
and mixed hamartoma of the liver in Beckwith-Wiedemann
syndrome: case study including analysis of H19 methylation
and insulin-like growth factor 2 genotyping and imprinting.
Pediatr Dev Pathol 2001;4:381–90.
5. Ramadan GI, Kennea NL. Beckwith-Wiedemann syndrome
associated with congenital hypothyroidism in a preterm
neonate: a case report and literature review. J Perinatol
2009;29:455-57.
6. Wiedemann HR. A new syndrome with hypoglicemia.
Monatsschr Kinderheilkd 1969;117:239-42.
7. DeBaun MR, King AA, White N. Hypoglycemia in BeckwithWiedemann syndrome. Semin Perinatol 2000;24:164-71.

Thank you for copying data from http://www.arastirmax.com